Skip to main content
Livermore
Livermore
ZHEN

Tobam

SEC CIK
0001527488
Latest filing
Jul 31, 2026

REGN holding history

Regeneron Pharmaceuticals, Inc. in every 13F filed by Tobam, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

REGN overviewAll 13F holders of REGNFull Q2 2026 holdings

Shares (Q2 2026)
2,394
Value
$1.49M
% of portfolio
0.4%
Quarters held
21
Since Q1 2021
Holdings of REGN by Tobam, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20262,394$1.49M0.4%+1,791+297.0%AddedHolders
Q1 2026603$466.0K0.1%+105+21.1%AddedHolders
Q4 2025498$384.0K0.1%+498NewHolders
Q3 20250$00.0%−2−100.0%Sold outHolders
Q2 20252$1.00K<0.1%00.0%UnchangedHolders
Q1 20252$1.00K<0.1%−595−99.7%ReducedHolders
Q4 2024597$425.0K0.1%−347−36.8%ReducedHolders
Q3 2024944$992.0K0.2%−114−10.8%ReducedHolders
Q2 20241,058$1.11M0.2%−2,517−70.4%ReducedHolders
Q1 20243,575$3.44M0.3%−989−21.7%ReducedHolders
Q4 20234,564$4.01M0.4%−730−13.8%ReducedHolders
Q3 20235,294$4.36M0.3%−2,274−30.0%ReducedHolders
Q2 20237,568$5.44M0.4%−7,161−48.6%ReducedHolders
Q1 202314,729$12.1M0.8%−5,577−27.5%ReducedHolders
Q4 202220,306$14.7M1.0%+6,251+44.5%AddedHolders
Q3 202214,055$9.68M0.7%−3,959−22.0%ReducedHolders
Q2 202218,014$10.6M0.7%−18,663−50.9%ReducedHolders
Q1 202236,677$25.6M1.3%+1,481+4.2%AddedHolders
Q4 202135,196$22.2M1.0%−9,721−21.6%ReducedHolders
Q3 202144,917$27.2M1.2%+2,499+5.9%AddedHolders
Q2 202142,418$23.7M0.9%−1,174−2.7%ReducedHolders
Q1 202143,592$20.6M0.9%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.